Contact
Please use this form to send email to PR contact of this press release:
MetP Pharma Receives US Patent for Drug Therapy of Demyelinating and Neuroinflammatory Diseases such as Multiple Sclerosis
TO:
Please use this form to send email to PR contact of this press release:
MetP Pharma Receives US Patent for Drug Therapy of Demyelinating and Neuroinflammatory Diseases such as Multiple Sclerosis
TO: